Xylem (XYL) Cash And Cash Equivalents : $1,019 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Xylem Cash And Cash Equivalents?

Xylem's quarterly cash and cash equivalents declined from Jun. 2023 ($708.00 Mil) to Sep. 2023 ($705.00 Mil) but then increased from Sep. 2023 ($705.00 Mil) to Dec. 2023 ($1,019.00 Mil).

Xylem's annual cash and cash equivalents declined from Dec. 2021 ($1,349.00 Mil) to Dec. 2022 ($944.00 Mil) but then increased from Dec. 2022 ($944.00 Mil) to Dec. 2023 ($1,019.00 Mil).

Xylem Cash And Cash Equivalents Historical Data

The historical data trend for Xylem's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylem Cash And Cash Equivalents Chart

Xylem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

724.00

1,875.00

1,349.00

944.00

1,019.00

Xylem Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															944.00	837.00	708.00	705.00	1,019.00

Xylem Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Xylem (NYSE:XYL) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Xylem Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Xylem's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Xylem (XYL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Xylem Inc (NYSE:XYL) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

XY6:Germany XY6:Germany XY6:Germany

Address

300 Water Street SE, Washington, DC, USA, 20003

Website

https://www.xylem.com

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $5.5 billion in revenue and $672 million in adjusted operating income in 2022.

Executives

Victoria D Harker	director	4300 WILSON BOULEVARD, ARLINGTON VA 22203
William K Grogan	officer: SVP & Chief Financial Officer	3100 SANDERS ROAD, SUITE 301, NORTHBROOK IL 60062
Patrick Decker	director, officer: President & CEO	9 ROSZEL ROAD, PRINCETON NJ 08540
Rodney Aulick	officer: SVP & President, IS&S	EVOQUA WATER TECHNOLOGIES CORP., 210 SIXTH AVENUE, PITTSBURGH PA 15222
Lisa Glatch	director	EVOQUA WATER TECHNOLOGIES CORP., 210 SIXTH AVENUE, PITTSBURGH PA 15222
Lynn C Swann	director	C/O AMERICAN HOMES 4 RENT, 23975 PARK SORRENTO, SUITE 300, CALABASAS CA 91302
Earl Ray Ellis	director	ONE LIBERTY PLAZA, 7TH FLOOR, NEW YORK NY 10006
Hayati Yarkadas	officer: Senior Vice President	C/O TRINSEO S.A., 1000 CHESTERBROOK BOULEVARD, SUITE 300, BERWYN PA 19312
Michael J. Mcgann	officer: Senior Vice President	301 WATER STREET, SUITE 200, WASHINGTON DC 20003
Matthew Francis Pine	officer: Senior Vice President	XYLEM INC., 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Claudia S Toussaint	officer: SVP, GC & Corporate Secretary	5454 W 110TH STREET, OVERLAND PARK KS 66211
Jeanne Beliveau-dunn	director	C/O XYLEM INC., 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Franz Cerwinka	officer: SVP and President, Emerging Ma	XYLEM INC., 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Sabol Colin R	officer: SVP & Chief Strategy Officer	9921 MONTIANO DRIVE, NAPLES FL 34113
Surya N Mohapatra	director	3 GIRALDA FARMS, MADISON NJ 07940